PATENT CLAIM ANALYSIS

Application Number: 15995584
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["530", "387100"]

Abstract:
The present invention is based, in part, on the identification of novel human anti-PD-1, PD-L1, and PD-L2 antibodies. Accordingly, the invention relates to compositions and methods for diagnosing, prognosing, and treating conditions that would benefit from modulating PD-1, PD-1, and/or PD-L2 activity (e.g., persistent infectious diseases autoimmune diseases, asthma, transplant rejection, inflammatory disorders and tumors) using the novel human anti-PD-1, PD-L1, and PD-L2 antibodies described herein.

Claim (Index 71):
A vector comprising the isolated nucleic acid of  claim 70 .

Metadata:
- Claim Count in Document: 35.0
- Percentile: 94.0
- Lexical Diversity: 1.57407
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13120406', '13802172', '14822651', '14248462', '15858963']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7148984739480573
- 35 USC 102 Novelty (BERT): 0.6196959317931698
- Combined Prediction Score: 0.7053782197325685
- Mean Citation Score: 599.014034
- Max Citation Score: 701.8463
- Similarity Product: 483.53717725766296

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test